Articles

Poll

Podcasts

Slideshows

Videos

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

View slated expert interviews and 6 clinical RA, PsA, and lupus trials to watch at ACR 2025.

Conference Preview: American College of Rheumatology Convergence 2025

The decision is supported by positive results from the phase 2 NOBILITY and phase 3 REGENCY studies.

FDA Approves Obinutuzumab (Gazyva) for Lupus Nephritis

However, a notable higher rate of treatment-related adverse events warrants caution.

Telitacicept Significantly Improves Lupus Response Rates Above SOC Alone 

The rheumatology month in review emphasizes new approvals and the latest comparative research.

7 Rheumatology Headlines You Missed in September 2025

Upadacitinib reduced glucocorticoid doses and improved disease activity over 104 weeks.

Upadacitinib Alone and With Elsubrutinib Continue to Yield SLE Responses in Long-Term Data

Sign o’ the Times: PAISLEY Study Hits the High Notes in Lupus Management

Shedding Light on Voclosporin for Lupus: AURORA 2 Finds No Increased Nephrotoxicity at 18 Months

The rheumatology month in review emphasizes new approvals and best-in-class efficacy data.

7 Rheumatology Headlines You Missed in August 2025

Santerus AG is preparing to initiate clinical trials of its blood purification technology in a variety of indications.

NucleoCapture Gets FDA Breakthrough Designation for Systemic Lupus Erythematosus

New phase 3 trial data reveals Dapirolizumab pegol significantly reduces disease activity and fatigue in systemic lupus erythematosus patients, promising improved treatment outcomes.